Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 17 studies | 47% ± 12% | |
| lung | 14 studies | 36% ± 14% | |
| intestine | 11 studies | 33% ± 16% | |
| brain | 8 studies | 26% ± 8% | |
| kidney | 7 studies | 33% ± 7% | |
| lymph node | 5 studies | 44% ± 6% | |
| liver | 5 studies | 38% ± 15% | |
| pancreas | 4 studies | 45% ± 14% | |
| bone marrow | 4 studies | 42% ± 18% | |
| eye | 4 studies | 24% ± 6% | |
| uterus | 4 studies | 55% ± 19% | |
| breast | 4 studies | 31% ± 6% | |
| placenta | 3 studies | 37% ± 10% | |
| prostate | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 4804.93 | 459 / 459 | 100% | 62.57 | 1118 / 1118 |
| esophagus | 100% | 4004.67 | 1445 / 1445 | 100% | 35.39 | 183 / 183 |
| ovary | 100% | 8075.73 | 180 / 180 | 100% | 46.27 | 430 / 430 |
| pancreas | 100% | 3231.25 | 328 / 328 | 100% | 44.70 | 178 / 178 |
| prostate | 100% | 4102.56 | 245 / 245 | 100% | 61.20 | 502 / 502 |
| uterus | 100% | 5300.35 | 170 / 170 | 100% | 54.52 | 459 / 459 |
| thymus | 100% | 3343.71 | 653 / 653 | 100% | 68.92 | 604 / 605 |
| intestine | 100% | 4697.49 | 966 / 966 | 100% | 58.88 | 526 / 527 |
| bladder | 100% | 4891.33 | 21 / 21 | 100% | 48.28 | 503 / 504 |
| stomach | 100% | 3724.79 | 359 / 359 | 100% | 54.54 | 285 / 286 |
| lung | 100% | 3129.51 | 576 / 578 | 100% | 43.03 | 1154 / 1155 |
| kidney | 100% | 3535.40 | 89 / 89 | 100% | 60.11 | 897 / 901 |
| brain | 99% | 2369.67 | 2627 / 2642 | 100% | 43.91 | 705 / 705 |
| liver | 100% | 1683.90 | 225 / 226 | 100% | 38.28 | 405 / 406 |
| adrenal gland | 100% | 4058.74 | 258 / 258 | 98% | 54.71 | 226 / 230 |
| skin | 100% | 4086.50 | 1807 / 1809 | 98% | 50.24 | 461 / 472 |
| adipose | 100% | 4707.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 80.71 | 29 / 29 |
| spleen | 100% | 3309.91 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 48.11 | 45 / 45 |
| blood vessel | 100% | 4498.98 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3665.48 | 801 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 66.46 | 78 / 80 |
| heart | 95% | 2330.79 | 822 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 84% | 2684.51 | 777 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000460 | Biological process | maturation of 5.8S rRNA |
| GO_0000470 | Biological process | maturation of LSU-rRNA |
| GO_0030687 | Cellular component | preribosome, large subunit precursor |
| GO_0005730 | Cellular component | nucleolus |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | NSA2 |
| Protein name | Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1) NSA2 ribosome biogenesis factor |
| Synonyms | TINP1 HUSSY-29 |
| Description | FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. May play a part in the quality control of pre-60S particles (By similarity). . |
| Accessions | ENST00000610426.5 ENST00000515524.1 O95478 A0A0A0MQZ6 ENST00000296802.9 H0YAI9 |